Sit Investment Associates’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.16M Buy
68,995
+12,770
+23% +$1.47M 0.15% 160
2026
Q1
$6.72M Sell
56,225
-14,460
-20% -$1.9M 0.14% 174
2025
Q4
$9.63M Sell
70,685
-647
-0.9% -$93.1K 0.19% 133
2025
Q3
$10.5M Sell
71,332
-6,818
-9% -$946K 0.21% 108
2025
Q2
$10.1M Sell
78,150
-4,125
-5% -$500K 0.22% 118
2025
Q1
$9.83M Buy
82,275
+16,395
+25% +$2.03M 0.23% 118
2024
Q4
$7.64M Buy
65,880
+57,593
+695% +$7.28M 0.17% 159
2024
Q3
$1.12M Buy
8,287
+3,436
+71% +$460K 0.03% 375
2024
Q2
$658K Sell
4,851
-17
-0.3% -$2.31K 0.02% 393
2024
Q1
$629K Buy
4,868
+3,828
+368% +$463K 0.01% 389
2023
Q4
$119K Buy
+1,040
New +$104K ﹤0.01% 496

Other funds holding XYL

Sit Investment Associates's XYL Position: Q2 2026 in Review

Sit Investment Associates increased its Xylem (XYL) stake by 23% in Q2 2026, buying an estimated $1.47M and bringing the position to 68,995 shares worth $8.16M. The position accounts for 0.15% of the portfolio, ranked #160.

Sit Investment Associates first reported a position in XYL in Q4 2023 and has held it in 11 quarters since. The position peaked at $10.5M in Q3 2025. 1,096 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Sit Investment Associates held 68,995 shares of Xylem worth $8.16M as of Q2 2026.
  • Sit Investment Associates bought 12,770 Xylem shares in Q2 2026, an estimated $1.47M.
  • Xylem made up 0.15% of Sit Investment Associates's portfolio in Q2 2026, its #160 holding.
  • Sit Investment Associates first reported a position in Xylem in Q4 2023 and has held it in 11 quarters since.
  • Sit Investment Associates's Xylem position peaked at $10.5M in Q3 2025.
  • 1,096 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Sit Investment Associates's 13F filing for Q2 2026, filed 12 Aug 2026.